Sign in

CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company

Ernexa Therapeutics Inc.

Sign in to watch
Ticker
ERNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
311103425
Phone
(617) 798-6700
Business address
1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
Former names
Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC

Securities

  • ERNA Common Stock Nasdaq
  • ERNAW Warrants Nasdaq
  1. 8-K Event Results of operations
  2. 4 Open-market sale 10% owner sold 8,400 shares at $0.36 ($2,984)
  3. 4 Open-market sale 10% owner sold 4,400 shares at $0.35 ($1,540)
  4. 4 Open-market sale 10% owner sold 60,000 shares at $0.31 ($18,630)
  5. 4 Open-market sale 10% owner sold 108,000 shares at $0.32 ($34,322)
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market sale 10% owner sold 65,000 shares at $0.31 ($20,150)
  8. 4 Open-market sale 10% owner sold 37,300 shares at an average $0.35 ($13,083)
  9. 8-K Event Executive or director change
  10. 4 Open-market sale 10% owner sold 300 shares at $0.37 ($111)
  11. 4 Open-market sale 10% owner sold 400 shares at $0.39 ($156)
  12. 4 Open-market sale 10% owner sold 2,100 shares at $0.39 ($819)
  13. 4 Open-market sale 10% owner sold 7,900 shares at $0.40 ($3,143)
  14. 4 Open-market sale 10% owner sold 2,000 shares at $0.39 ($780)
  15. 4 Open-market sale 10% owner sold 2,000 shares at $0.39 ($780)
  16. 4 Open-market sale 10% owner sold 10,000 shares at $0.47 ($4,726)
  17. 4 Open-market sale 10% owner sold 15,000 shares at $0.46 ($6,876)
  18. 4 Option exercise CEO acquired 175,833 shares (option exercise)
  19. 4/A Open-market buy Director bought 1,250,000 shares at $0.13 ($162,500)
  20. 4/A Open-market buy Director bought 1,544,145 shares at an average $0.25 ($384,712)

Page 53 of 77 · 1,525 filings